1. Home
  2. CRGY vs AGIO Comparison

CRGY vs AGIO Comparison

Compare CRGY & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGY
  • AGIO
  • Stock Information
  • Founded
  • CRGY 1986
  • AGIO 2007
  • Country
  • CRGY United States
  • AGIO United States
  • Employees
  • CRGY N/A
  • AGIO N/A
  • Industry
  • CRGY Oil & Gas Production
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRGY Energy
  • AGIO Health Care
  • Exchange
  • CRGY Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • CRGY 2.3B
  • AGIO 2.5B
  • IPO Year
  • CRGY N/A
  • AGIO 2013
  • Fundamental
  • Price
  • CRGY $9.16
  • AGIO $28.01
  • Analyst Decision
  • CRGY Buy
  • AGIO Buy
  • Analyst Count
  • CRGY 10
  • AGIO 8
  • Target Price
  • CRGY $14.56
  • AGIO $31.29
  • AVG Volume (30 Days)
  • CRGY 6.6M
  • AGIO 2.2M
  • Earning Date
  • CRGY 11-03-2025
  • AGIO 10-30-2025
  • Dividend Yield
  • CRGY 5.22%
  • AGIO N/A
  • EPS Growth
  • CRGY N/A
  • AGIO N/A
  • EPS
  • CRGY 0.10
  • AGIO N/A
  • Revenue
  • CRGY $3,590,024,000.00
  • AGIO $44,791,000.00
  • Revenue This Year
  • CRGY $29.58
  • AGIO $25.57
  • Revenue Next Year
  • CRGY $29.49
  • AGIO $153.24
  • P/E Ratio
  • CRGY $88.49
  • AGIO N/A
  • Revenue Growth
  • CRGY 32.31
  • AGIO 36.26
  • 52 Week Low
  • CRGY $6.83
  • AGIO $22.24
  • 52 Week High
  • CRGY $16.94
  • AGIO $62.45
  • Technical
  • Relative Strength Index (RSI)
  • CRGY 55.71
  • AGIO 34.01
  • Support Level
  • CRGY $8.22
  • AGIO $23.00
  • Resistance Level
  • CRGY $9.23
  • AGIO $25.98
  • Average True Range (ATR)
  • CRGY 0.52
  • AGIO 2.18
  • MACD
  • CRGY 0.03
  • AGIO -1.91
  • Stochastic Oscillator
  • CRGY 60.36
  • AGIO 24.37

About CRGY Crescent Energy Company

Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: